CEDOPEC-Ctro Esp en Diab, Obesidad y Prev de Enf Cardiovasc
México C.P. 11650
0 studies enrolling now · 5 studies all time
What they study most
Diabetes Mellitus, Type 2, Heart Failure, Kidney Disease, Chronic, Obesity
Studies at this site
- A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT) — Completed
- A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease — Completed
- EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) — Completed
- EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced) — Completed
- Linagliptin as Add on to Basal Insulin in the Elderly — Completed